Veritex Holdings, Inc. - Common Stock (VBTX)
21.34
-0.99 (-4.43%)
NASDAQ · Last Trade: Apr 4th, 10:11 PM EDT

As the US market prepares to open on Monday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
Via Chartmill · February 3, 2025

Via Benzinga · September 17, 2024

Via Benzinga · August 28, 2024

Via Benzinga · April 1, 2024

VBTX stock results show that Veritex Holdings missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via InvestorPlace · July 23, 2024

VBTX stock results show that Veritex Holdings missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via InvestorPlace · April 23, 2024

US banks with large CRE loan portfolios face increased regulatory scrutiny, but NYCB stands out with steady growth despite exceeding threshold.
Via Benzinga · February 15, 2024

Although sleeper stocks to buy may seem incredibly boring at first, these analyst-backed ideas could change your mind.
Via InvestorPlace · September 13, 2023

Trading at low earnings multiples, and at big discounts to book value, these are the most undervalued bank stocks.
Via InvestorPlace · September 12, 2023

Companies Reporting Before The Bell • RTX (NYSE:RTX) is expected to report quarterly earnings at $1.23 per share on revenue of $18.41 billion.
Via Benzinga · April 23, 2024

Companies Reporting Before The Bell • Webster Finl (NYSE:WBS) is estimated to report quarterly earnings at $1.46 per share on revenue of $603.11 million.
Via Benzinga · January 23, 2024

Via Benzinga · July 5, 2023

On Thursday, 498 companies reached new 52-week lows.
Via Benzinga · May 4, 2023

These aren’t just your garden-variety value stocks to buy. Rather, if you can handle the risk, these ideas could double in price.
Via InvestorPlace · April 16, 2023

Gainers Ainos, Inc. (NASDAQ: AIMD) shares jumped 69.3% to $1.27 after the company announced it signed a Memorandum of Understanding with Merdury Biopharmaceutical to jointly explore and develop a strategic business relationship.
Via Benzinga · March 14, 2023